1- Department of Biology, School of Basic Sciences, Science and Research Branch, Islamic Azad University, Tehran, Iran 2- Department of Medical Genetics, National Research Institute of Genetic Engineering and Biotechnology, Tehran, Iran 3- Department of Biochemistry, National Institute of Genetic Engineering and Biotechnology, Tehran, Iran 4- Department of Industrial and Environmental Biotechnology, National Institute of Genetic, Engineering and Biotechnology, Tehran, Iran , article.school2022@gmail.com
Abstract: (264 Views)
Background: Induced stem cell production technology has made diabetic patients more hopeful for alternative treatment. Recently, it has been shown that the use of growth factor micromolecules can play a role in increasing insulin production. Materials and methods: In this study, the effect of growth factors (TGF-β, EGF and HGF) and small molecules (harmin and WS6) on insulin production by beta cells was evaluated. Insulin gene expression was evaluated using RT-PCR. Also, the amount of secreted insulin was measured by ELISA. Using the MTT test, the survival rate of beta cells treated with growth factors and micromolecules was evaluated. Results: The results of ELISA and western blot showed that the use of WS6 and harmine along with the simultaneous use of EGH, HGF and TGF-β increased protein expression and insulin secretion compared to each alone (p<0.05). Also, the expression of insulin gene was increased according to them. The survival time of the cells treated with growth factors and micromolecules was suitable, and with the increase in their concentration, cell death of beta cells occurred. Conclusion: it can be said that the use of micromolecules and growth factors can have a significant effect on the proliferation of beta cells and insulin production
1. Enderami SE, Kehtari M, Abazari MF, Ghoraeian P, Nouri Aleagha M, Soleimanifar F, et al. Generation of insulin-producing cells from human induced pluripotent stem cells on PLLA/PVA nanofiber scaffold. Artif Cells Nanomed Biotechnol 2018;46:1062-1069. [DOI:10.1080/21691401.2018.1443466]
2. Aamodt KI, Powers AC. Signals in the pancreatic islet microenvironment influence β‐cell proliferation. Diabetes Obes Metab 2017;19:124-36. [DOI:10.1111/dom.13031]
3. Strand BL, Coron AE, Skjak‐Braek G. Current and future perspectives on alginate encapsulated pancreatic islet. Stem Cells Transl Med 2017;6:1053-8. [DOI:10.1002/sctm.16-0116]
4. Bellin MD, Dunn TB. Transplant strategies for type 1 diabetes: whole pancreas, islet and porcine beta cell therapies. Diabetologia 2020;63:2049-56. [DOI:10.1007/s00125-020-05184-7]
5. Paez-Mayorga J, Lukin I, Emerich D, de Vos P, Orive G, Grattoni A. Emerging strategies for beta cell transplantation to treat diabetes. Trends Pharmacol Sci 2022;43:221-33. [DOI:10.1016/j.tips.2021.11.007]
6. Zhong L, Li Y, Xiong L, Wang W, Wu M, Yuan T, et al. Small molecules in targeted cancer therapy: advances, challenges, and future perspectives. Signal Transduct Target Ther 2021;6:1-48. [DOI:10.1038/s41392-021-00572-w]
7. Balboa D, Barsby T, Lithovius V, Saarimäki-Vire J, Omar-Hmeadi M, Dyachok O, et al. Functional, metabolic and transcriptional maturation of human pancreatic islets derived from stem cells. Nat Biotechnol 2022;40:1042-55. [DOI:10.1038/s41587-022-01219-z]
8. Ying W, Fu W, Lee YS, Olefsky JM. The role of macrophages in obesity-associated islet inflammation and β-cell abnormalities. Nat Rev Endocrinol 2020;16:81-90. [DOI:10.1038/s41574-019-0286-3]
9. Boerner BP, George NM, Mir SU, Sarvetnick NE. WS6 induces both alpha and beta cell proliferation without affecting differentiation or viability. Endocr J 2015;62:379-86. [DOI:10.1507/endocrj.EJ14-0449]
10. Shen W, Tremblay MS, Deshmukh VA, Wang W, Filippi CM, Harb G, et al. Small-molecule inducer of β cell proliferation identified by high-throughput screening. J Am Chem Soc 2013;135:1669-72. [DOI:10.1021/ja309304m]
11. Barzowska A, Pucelik B, Pustelny K, Matsuda A, Martyniak A, Stępniewski J, et al. DYRK1A Kinase inhibitors promote β-cell survival and insulin homeostasis. Cells. 2021;10(9):2263. doi: 10.3390/cells10092263 [DOI:10.3390/cells10092263]
12. Title AC, Karsai M, Mir-Coll J, Grining ÖY, Rufer C, Sonntag S, et al. Evaluation of the Effects of Harmine on β-cell Function and Proliferation in Standardized Human Islets Using 3D High-Content Confocal Imaging and Automated Analysis. Front Endocrinol (Lausanne) 2022;13:854094. [DOI:10.3389/fendo.2022.854094]
13. Enderami SE, Mortazavi Y, Soleimani M, Nadri S, Biglari A, Mansour RN. Generation of insulin‐producing cells from human‐induced pluripotent stem cells using a stepwise differentiation protocol optimized with platelet‐rich plasma. J Cell Physiol 2017;232:2878-86. [DOI:10.1002/jcp.25721]
14. Li N, Jiang D, He Q, He F, Li Y, Deng C, et al. microRNA-181c-5p promotes the formation of insulin-producing cells from human induced pluripotent stem cells by targeting smad7 and TGIF2. Cell Death Dis 2020;11:462. [DOI:10.1038/s41419-020-2668-9]
15. Gao Y, Zhang R, Dai S, Zhang X, Li X, Bai C. Role of TGF-β/Smad pathway in the transcription of pancreas-specific genes during beta cell differentiation. Front Cell Dev Biol 2019;7:351. [DOI:10.3389/fcell.2019.00351]
16. Mansour RN, Barati G, Soleimani M, Ghoraeian P, Nouri Aleagha M, Kehtari M, et al. Generation of high-yield insulin producing cells from human-induced pluripotent stem cells on polyethersulfone nanofibrous scaffold. Artif Cells Nanomed Biotechnol 2018;46:S733-39. [DOI:10.1080/21691401.2018.1434663]
Akhavan S, Sanati M H, Irani S, Soheili Z, Arpanaei A. Investigating the effect of micromolecules and growth factors on the proliferation of pancreatic beta cells derived from the proliferation of human induced pluripotent cells. MEDICAL SCIENCES 2025; 35 (2) :129-135 URL: http://tmuj.iautmu.ac.ir/article-1-2278-en.html